IRIS Accounts Production v25.1.4.42 07573074 Board of Directors Board of Directors 1.1.24 31.12.24 31.12.24 false true false false false true false 376610 349572 75875 27038 452485 376610 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh075730742023-12-31075730742024-12-31075730742024-01-012024-12-31075730742022-12-31075730742023-01-012023-12-31075730742023-12-3107573074ns15:EnglandWales2024-01-012024-12-3107573074ns14:PoundSterling2024-01-012024-12-3107573074ns10:Director12024-01-012024-12-3107573074ns10:Director22024-01-012024-12-3107573074ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3107573074ns10:SmallEntities2024-01-012024-12-3107573074ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3107573074ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3107573074ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3107573074ns10:FullAccounts2024-01-012024-12-310757307412024-01-012024-12-3107573074ns10:Director1412023-12-3107573074ns10:Director1412022-12-3107573074ns10:Director1412024-01-012024-12-3107573074ns10:Director1412023-01-012023-12-3107573074ns10:Director1412024-12-3107573074ns10:Director1412023-12-3107573074ns10:CompanySecretary12024-01-012024-12-3107573074ns10:RegisteredOffice2024-01-012024-12-3107573074ns5:CurrentFinancialInstruments2024-12-3107573074ns5:CurrentFinancialInstruments2023-12-3107573074ns5:Non-currentFinancialInstruments2024-12-3107573074ns5:Non-currentFinancialInstruments2023-12-3107573074ns5:ShareCapital2024-12-3107573074ns5:ShareCapital2023-12-3107573074ns5:RetainedEarningsAccumulatedLosses2024-12-3107573074ns5:RetainedEarningsAccumulatedLosses2023-12-3107573074ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107573074ns5:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3107573074ns5:PlantMachinery2024-01-012024-12-3107573074ns5:IntangibleAssetsOtherThanGoodwill2023-12-3107573074ns5:IntangibleAssetsOtherThanGoodwill2024-12-3107573074ns5:IntangibleAssetsOtherThanGoodwill2023-12-3107573074ns5:PlantMachinery2023-12-3107573074ns5:PlantMachinery2024-12-3107573074ns5:PlantMachinery2023-12-3107573074ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3107573074ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3107573074ns10:Director222023-12-3107573074ns10:Director222022-12-3107573074ns10:Director222024-01-012024-12-3107573074ns10:Director222023-01-012023-12-3107573074ns10:Director222024-12-3107573074ns10:Director222023-12-31
REGISTERED NUMBER: 07573074 (England and Wales)












Financial Statements

for the Year Ended 31 December 2024

for

Purple Plastic Surgery Limited

Purple Plastic Surgery Limited (Registered number: 07573074)

Contents of the Financial Statements
for the Year Ended 31 December 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Purple Plastic Surgery Limited

Company Information
for the Year Ended 31 December 2024







DIRECTORS: Dr S W McKirdy
Mrs L McKirdy





SECRETARY:





REGISTERED OFFICE: Bridge Street
Garstang
Preston
Lancashire
PR3 1YB





REGISTERED NUMBER: 07573074 (England and Wales)





ACCOUNTANTS: Towers + Gornall Ltd
Chartered Certified Accountants
River View
96 High Street
Garstang
Preston
Lancashire
PR3 1WZ

Purple Plastic Surgery Limited (Registered number: 07573074)

Balance Sheet
31 December 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Property, plant and equipment 5 12,673 15,081
12,673 15,081

CURRENT ASSETS
Inventories 4,500 3,000
Debtors 6 604,459 491,767
Cash at bank 7,925 15,163
616,884 509,930
CREDITORS
Amounts falling due within one year 7 79,692 38,542
NET CURRENT ASSETS 537,192 471,388
TOTAL ASSETS LESS CURRENT
LIABILITIES

549,865

486,469

CREDITORS
Amounts falling due after more than one
year

8

(2,880

)

(12,092

)

PROVISIONS FOR LIABILITIES (3,052 ) (3,343 )
NET ASSETS 543,933 471,034

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 543,833 470,934
543,933 471,034

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Purple Plastic Surgery Limited (Registered number: 07573074)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 June 2025 and were signed on its behalf by:




Mrs L McKirdy - Director



Dr S W McKirdy - Director


Purple Plastic Surgery Limited (Registered number: 07573074)

Notes to the Financial Statements
for the Year Ended 31 December 2024


1. STATUTORY INFORMATION

Purple Plastic Surgery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of five years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance and 25% on cost

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

Purple Plastic Surgery Limited (Registered number: 07573074)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2024
and 31 December 2024 906
AMORTISATION
At 1 January 2024
and 31 December 2024 906
NET BOOK VALUE
At 31 December 2024 -
At 31 December 2023 -

5. PROPERTY, PLANT AND EQUIPMENT
Plant and
machinery
etc
£   
COST
At 1 January 2024 26,428
Additions 2,354
At 31 December 2024 28,782
DEPRECIATION
At 1 January 2024 11,347
Charge for year 4,762
At 31 December 2024 16,109
NET BOOK VALUE
At 31 December 2024 12,673
At 31 December 2023 15,081

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 10,561 8,323
Other debtors 593,898 483,444
604,459 491,767

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 9,212 8,985
Trade creditors 1,200 1,600
Taxation and social security 62,148 25,263
Other creditors 7,132 2,694
79,692 38,542

Purple Plastic Surgery Limited (Registered number: 07573074)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024


8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loans 2,880 12,092

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 December 2024 and 31 December 2023:

2024 2023
£    £   
Dr S W McKirdy and Mrs L McKirdy
Balance outstanding at start of year 376,610 349,572
Amounts advanced 75,875 27,038
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 452,485 376,610

The loan account is operated as a joint account belonging to both S W McKirdy and L McKirdy.

Interest has been charged on the outstanding loan account balance due from the directors at 2.25% per annum.

The loans are repayable upon demand by the company.